These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33801209)

  • 21. VCP/p97 targets the nuclear export and degradation of p27
    Shi X; Zhu K; Ye Z; Yue J
    FASEB J; 2020 Apr; 34(4):5193-5207. PubMed ID: 32067276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
    Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic p27
    Calvayrac O; Nowosad A; Cabantous S; Lin LP; Figarol S; Jeannot P; Serres MP; Callot C; Perchey RT; Creff J; Taranchon-Clermont E; Rouquette I; Favre G; Pradines A; Manenti S; Mazieres J; Lee H; Besson A
    J Pathol; 2019 Jan; 247(1):60-71. PubMed ID: 30206932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.
    Vert A; Castro J; Ribó M; Benito A; Vilanova M
    Oncotarget; 2016 Apr; 7(14):18309-24. PubMed ID: 26918450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27
    Shen X; Xu X; Xie C; Liu H; Yang D; Zhang J; Wu Q; Feng W; Wang L; Du L; Xuan L; Meng C; Zhang H; Wang W; Wang Y; Xie T; Huang Z
    Cell Prolif; 2020 Feb; 53(2):e12734. PubMed ID: 31863533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple mechanisms for p27(Kip1) translocation and degradation.
    Susaki E; Nakayama KI
    Cell Cycle; 2007 Dec; 6(24):3015-20. PubMed ID: 18075313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.
    Indovina P; Giorgi F; Rizzo V; Khadang B; Schenone S; Di Marzo D; Forte IM; Tomei V; Mattioli E; D'Urso V; Grilli B; Botta M; Giordano A; Pentimalli F
    Oncogene; 2012 Feb; 31(7):929-38. PubMed ID: 21785466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
    Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
    EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas.
    Sarek G; Järviluoma A; Ojala PM
    Blood; 2006 Jan; 107(2):725-32. PubMed ID: 16160006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor.
    Zeng Y; Hirano K; Hirano M; Nishimura J; Kanaide H
    Biochem Biophys Res Commun; 2000 Jul; 274(1):37-42. PubMed ID: 10903892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and relationship of p27(kip1) and its related molecules Jab1 and CRM1 during proliferation of lymphoma cells U937].
    Wang YC; Zhang DM; Shen AG; Lu JX; Shao XY; He S; Cheng C
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):657-61. PubMed ID: 18246793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Akt signalling in non-seminomatous testicular germ cell tumors.
    Hennenlotter J; Amend B; Vogel U; Renninger M; Springer C; Kuehs U; Stenzl A; Bedke J
    Anticancer Res; 2011 Nov; 31(11):3783-8. PubMed ID: 22110200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
    Jiang D; Wang X; Liu X; Li F
    Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.
    Wang DD; Li J; Sha HH; Chen X; Yang SJ; Shen HY; Zhong SL; Zhao JH; Tang JH
    Gene; 2016 Sep; 590(1):44-50. PubMed ID: 27282281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
    Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL
    Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.
    Fredersdorf S; Burns J; Milne AM; Packham G; Fallis L; Gillett CE; Royds JA; Peston D; Hall PA; Hanby AM; Barnes DM; Shousha S; O'Hare MJ; Lu X
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6380-5. PubMed ID: 9177226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells.
    Hung WC; Chang HC; Pan MR; Lee TH; Chuang LY
    Mol Pharmacol; 2000 Dec; 58(6):1398-403. PubMed ID: 11093779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
    Lu Y; Zi X; Pollak M
    Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.